139 related articles for article (PubMed ID: 2851187)
21. [Paraneoplastic syndrome by hormone-like substances].
Mihara M; Hirata Y
Nihon Rinsho; 2011 Mar; 69 Suppl 2():721-4. PubMed ID: 21830627
[No Abstract] [Full Text] [Related]
22. Paraneoplastic hypercalcemia associated with juvenile granulosa cell tumor.
Rupprich K; Wimberger P; Wieland R; Eggert A; Grabellus F; Schneider DT; Wulff B
Klin Padiatr; 2013 May; 225(3):170-1. PubMed ID: 23519754
[No Abstract] [Full Text] [Related]
23. [Lung cancer and paraneoplastic syndromes].
Jurado Gámez B; García de Lucas MD; Gudín Rodríguez M
An Med Interna; 2001 Aug; 18(8):440-6. PubMed ID: 11589085
[TBL] [Abstract][Full Text] [Related]
24. [Paraneoplastic para-endocrine syndromes].
Dolcino G
Arch Maragliano Patol Clin; 1969; 25(4):323-43. PubMed ID: 5408927
[No Abstract] [Full Text] [Related]
25. Common paraneoplastic syndromes.
Finora K
Clin Tech Small Anim Pract; 2003 May; 18(2):123-6. PubMed ID: 12831075
[TBL] [Abstract][Full Text] [Related]
26. The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma.
Soutelo J; Moldes S; Frisone C; Salvá L; Agostinis C; Faraj G
Arch Endocrinol Metab; 2017; 61(1):98-102. PubMed ID: 27737327
[TBL] [Abstract][Full Text] [Related]
27. [Mechanism of tumor hypercalcemia].
Baglin A; Prinseau J
Ann Med Interne (Paris); 1993; 144(1):35-41. PubMed ID: 8503605
[No Abstract] [Full Text] [Related]
28. Paraneoplastic syndromes: what we know and what we should know.
Tonini G; Vincenzi B; Santini D
Clin Ter; 2006; 157(2):93-4. PubMed ID: 16817496
[TBL] [Abstract][Full Text] [Related]
29. Paraneoplastic syndromes: an approach to diagnosis and treatment.
Pelosof LC; Gerber DE
Mayo Clin Proc; 2010 Sep; 85(9):838-54. PubMed ID: 20810794
[TBL] [Abstract][Full Text] [Related]
30. [Paraneoplastic syndromes: concept and limits. Viewpoint of the internist and the dermatologist].
Gilsanz García V; Gómez Orbaneja J
An R Acad Nac Med (Madr); 1985; 102(4):353-84. PubMed ID: 3832962
[No Abstract] [Full Text] [Related]
31. [Tumor markers in bronchial carcinoma. Parameters for early diagnosis, staging and treatment follow-up].
Gropp C; Luster W
Ric Clin Lab; 1984; 14 Suppl 2():21-31. PubMed ID: 6099605
[No Abstract] [Full Text] [Related]
32. Endocrine manifestations of cancer and its treatment.
Shalet SM
Practitioner; 1981 Jun; 225(1356):829-36. PubMed ID: 7301756
[No Abstract] [Full Text] [Related]
33. [Paraneoplastic endocrinopathies].
Tuschy U; von Paris V; Anger G; Senf L
Z Gesamte Inn Med; 1987 Jan; 42(1):27-9. PubMed ID: 3577265
[TBL] [Abstract][Full Text] [Related]
34. Paraendocrine syndromes.
Pierce ST
Curr Opin Oncol; 1993 Jul; 5(4):639-45. PubMed ID: 8364080
[TBL] [Abstract][Full Text] [Related]
35. [The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma].
Huh UY; Kim JH; Kim BH; Nam KD; Jang JY; Kim NH; Lee SK; Joo KR; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Korean J Hepatol; 2005 Sep; 11(3):275-83. PubMed ID: 16177554
[TBL] [Abstract][Full Text] [Related]
36. Nonmetastatic extrapulmonary manifestations of bronchogenic carcinoma.
Sealy WC
Surgery; 1970 Nov; 68(5):906-13. PubMed ID: 4319683
[No Abstract] [Full Text] [Related]
37. [Endocrine paraneoplastic syndrome].
Jacobasch KH
Arch Geschwulstforsch; 1967; 30(3):245-64. PubMed ID: 4876251
[No Abstract] [Full Text] [Related]
38. The Case | Pancreatitis with hypercalcemia.
Chen KC; Liao CY; Huang WC
Kidney Int; 2019 Jun; 95(6):1521-1522. PubMed ID: 31122712
[No Abstract] [Full Text] [Related]
39. [Paraneoplastic syndrome of hepatocellular carcinoma].
Tagawa K; Uta Y
Ryoikibetsu Shokogun Shirizu; 1995; (7):453-5. PubMed ID: 8749523
[No Abstract] [Full Text] [Related]
40. Endocrine abnormalities in bronchial carcinoma.
Br Med J; 1968 Oct; 4(5622):5. PubMed ID: 4300297
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
